Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model

Abstract

Although successful, drug-eluting stents require significant periods of dual anti-platelet therapy with a persistent risk of late stent thrombosis due to inhibition of re-endothelialization. Endothelial regeneration is desirable to protect against in-stent thrombosis. Gene-eluting stents may be an alternative allowing inhibition of neointima and regenerating endothelium. We have shown that adenoviral endothelial nitric oxide synthase (eNOS) delivery can result in significantly decreased neointimal formation and enhanced re-endothelialization. Here, we examined non-viral reporter and therapeutic gene delivery from a stent. We coated lipoplexes directly onto the surface of stents. These lipostents were then deployed in the injured external iliac artery of either normal or hypercholesterolemic New Zealand White rabbits and recovered after 28 days. Lipoplexes composed of lipofectin and a reporter lacZ gene or therapeutic eNOS gene were used. We demonstrated efficient gene delivery at 28 days post-deployment in the media (21.3±7.5%) and neointima (26.8±11.2%). Liposomal delivery resulted in expression in macrophages between the stent struts. This resulted in improved re-endothelialization as detected by two independent measures compared with vector and stent controls (P<0.05 for both). However, in contrast to viral delivery of eNOS, liposomal eNOS does not reduce restenosis rates. The differing cell populations targeted by lipoplexes compared with adenoviral vectors may explain their ability to enhance re-endothelialization without affecting restenosis. Liposome-mediated gene delivery can result in prolonged and localized transgene expression in the blood vessel wall in vivo. Furthermore, lipoeNOS delivery to the blood vessel wall results in accelerated re-endothelialization; however, it does not reduce neointimal formation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Carter AJ, Aggarwal M, Kopia GA, Tio F, Tsao PS, Kolata R et al. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 2004; 63: 617–624.

    Article  CAS  Google Scholar 

  2. Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky R et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104: 1188–1193.

    Article  CAS  Google Scholar 

  3. Heldman AW, Cheng L, Jenkins GM, Heller PF, Kim DW, Ware Jr M et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 2001; 103: 2289–2295.

    Article  CAS  Google Scholar 

  4. Virmani R, Farb A, Guagliumi G, Kolodgie FD . Drug-eluting stents: caution and concerns for long-term outcome. Coron Artery Dis 2004; 15: 313–318.

    Article  Google Scholar 

  5. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193–202.

    Article  Google Scholar 

  6. Sharif F, Hynes SO, McMahon J, Cooney R, Conroy S, Dockery P et al. Gene-eluting stents: comparison of adenoviral and adeno-associated viral gene delivery to the blood vessel wall in vivo. Hum Gene Ther 2006; 17: 741–750.

    Article  CAS  Google Scholar 

  7. Johnson TW, Wu YX, Herdeg C, Baumbach A, Newby AC, Karsch KR et al. Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries. Arterioscler Thromb Vasc Biol 2005; 25: 754–759.

    Article  CAS  Google Scholar 

  8. Walter DH, Cejna M, Diaz-Sandoval L, Willis S, Kirkwood L, Stratford PW et al. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 2004; 110: 36–45.

    Article  CAS  Google Scholar 

  9. Fishbein I, Alferiev I, Bakay M, Stachelek SJ, Sobolewski P, Lai M et al. Local delivery of gene vectors from bare-metal stents by use of a biodegradable synthetic complex inhibits in-stent restenosis in rat carotid arteries. Circulation 2008; 117: 2096–2103.

    Article  CAS  Google Scholar 

  10. Perlstein I, Connolly JM, Cui X, Song C, Li Q, Jones PL et al. DNA delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: mechanisms of enhanced transfection. Gene Therapy 2003; 10: 1420–1428.

    Article  CAS  Google Scholar 

  11. Cooney R, Hynes SO, Sharif F, Howard L, O’Brien T . Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury. Gene Therapy 2007; 14: 396–404.

    Article  CAS  Google Scholar 

  12. Sharif F, Hynes SO, Cooney R, Howard L, McMahon J, Daly K et al. Gene-eluting stents: adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis. Mol Ther 2008; 16: 1674–1680.

    Article  CAS  Google Scholar 

  13. Kullo IJ, Mozes G, Schwartz RS, Gloviczki P, Crotty TB, Barber DA et al. Adventitial gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries alters vascular reactivity. Circulation 1997; 96: 2254–2261.

    Article  CAS  Google Scholar 

  14. Newman KD, Dunn PF, Owens JW, Schulick AH, Virmani R, Sukhova G et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 1995; 96: 2955–2965.

    Article  CAS  Google Scholar 

  15. Leclerc G, Gal D, Takeshita S, Nikol S, Weir L, Isner JM . Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries. J Clin Invest 1992; 90: 936–944.

    Article  CAS  Google Scholar 

  16. Flugelman MY, Jaklitsch MT, Newman KD, Casscells W, Bratthauer GL, Dichek DA . Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter. Circulation 1992; 85: 1110–1117.

    Article  CAS  Google Scholar 

  17. Brito LA, Chandrasekhar S, Little SR, Amiji MM . In vitro and in vivo studies of local arterial gene delivery and transfection using lipopolyplexes-embedded stents. J Biomed Mat Res 2010; 93: 325–336.

    Google Scholar 

  18. Fishbein I, Alferiev IS, Nyanguile O, Gaster R, Vohs JM, Wong GS et al. Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents. Proc Natl Acad Sci USA 2006; 103: 159–164.

    Article  CAS  Google Scholar 

  19. Rogers C, Parikh S, Seifert P, Edelman ER . Endogenous cell seeding. Remnant endothelium after stenting enhances vascular repair. Circulation 1996; 94: 2909–2914.

    Article  CAS  Google Scholar 

  20. Lee ER, Marshall J, Siegel CS, Jiang C, Yew NS, Nichols MR et al. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum Gene Ther 1996; 7: 1701–1717.

    Article  CAS  Google Scholar 

  21. Schwartz B, Benoist C, Abdallah B, Scherman D, Behr JP, Demeneix BA . Lipospermine-based gene transfer into the newborn mouse brain is optimized by a low lipospermine/DNA charge ratio. Hum Gene Ther 1995; 6: 1515–1524.

    Article  CAS  Google Scholar 

  22. Liu F, Qi H, Huang L, Liu D . Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Therapy 1997; 4: 517–523.

    Article  CAS  Google Scholar 

  23. Yang JP, Huang L . Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Therapy 1997; 4: 950–960.

    Article  CAS  Google Scholar 

  24. Nakazawa G, Granada JF, Alviar CL, Tellez A, Kaluza GL, Guilhermier MY et al. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC Cardiovasc Interv 2010; 3: 68–75.

    Article  Google Scholar 

  25. Poppa V, Miyashiro JK, Corson MA, Berk BC . Endothelial NO synthase is increased in regenerating endothelium after denuding injury of the rat aorta. Arterioscler Thromb Vasc Biol 1998; 18: 1312–1321.

    Article  CAS  Google Scholar 

  26. Urao N, Okigaki M, Yamada H, Adachi Y, Matsuno K, Matsui A et al. Erythropoietin-mobilised endothelial progenitors enhance reendothelialisation via AKT-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 2006; 98: 1405–1413.

    Article  CAS  Google Scholar 

  27. Tsai TT, Ho PM, Xu S, Powers JD, Carroll NM, Shetterly SM et al. Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent). Circ Cardiovasc Interv 2010; 3: 230–235.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work is funded by an Enterprise Ireland Grant (CFTD 105-07). TOB is also funded by a CSET Grant to REMEDI from Science Foundation Ireland. KMC has received funding from the Health Research Board Ireland. We wish to acknowledge the help of Dr Ailish Hynes, Department of Physiology, NUI Galway, in the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T O'Brien.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharif, F., Hynes, S., McCullagh, K. et al. Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model. Gene Ther 19, 321–328 (2012). https://doi.org/10.1038/gt.2011.92

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2011.92

Keywords

This article is cited by

Search

Quick links